Terms: = Kidney tumors AND PPFIBP1, L2, 8496, ENSG00000110841, hSGT2, hSgt2p
88 results:
1. Soluble Immune Checkpoint Molecules as Predictors of Efficacy in Immuno-Oncology Combination Therapy in Advanced Renal Cell Carcinoma.
Ueda K; Uemura K; Ito N; Sakai Y; Ohnishi S; Suekane H; Kurose H; Hiroshige T; Chikui K; Nishihara K; Nakiri M; Suekane S; Ogasawara S; Yano H; Igawa T
Curr Oncol; 2024 Mar; 31(4):1701-1712. PubMed ID: 38668032
[TBL] [Abstract] [Full Text] [Related]
2. Preclinical Evaluation of a New Series of Albumin-Binding
Boinapally S; Alati S; Jiang Z; Yan Y; Lisok A; Singh R; Lofland G; Minn I; Hobbs RF; Pomper MG; Banerjee SR
Molecules; 2023 Aug; 28(16):. PubMed ID: 37630410
[TBL] [Abstract] [Full Text] [Related]
3. CD44 Is a Prognostic Biomarker Correlated With Immune Infiltrates and Metastasis in Clear Cell Renal Cell Carcinoma.
Ma J; Wu R; Chen Z; Zhang Y; Zhai W; Zhu R; Zheng J
Anticancer Res; 2023 Aug; 43(8):3493-3506. PubMed ID: 37500138
[TBL] [Abstract] [Full Text] [Related]
4. Molecular analysis and favorable clinical outcomes in real-world patients with metastatic renal cell carcinoma.
Donskov F; Pinto CA; Predoiu R; Fox C; Georgsen JB; Skaarup K; Burcu M; Perini R; Steiniche T
Acta Oncol; 2022 Oct; 61(10):1268-1277. PubMed ID: 36112410
[TBL] [Abstract] [Full Text] [Related]
5. The Prognostic Impact of PD-L2 in Papillary Renal-Cell Carcinoma.
Mondorf Y; Mikuteit M; Ivanyi P; Stöhr C; Herrmann E; Polifka I; Agaimy A; Trojan L; Ströbel P; Becker F; Wülfing C; Barth P; Stöckle M; Staehler M; Stief CG; Haferkamp A; Hohenfellner M; Macher-Göppinger S; Wullich B; Noldus J; Brenner W; Roos FC; Walter B; Otto W; Burger M; Schrader AJ; Hartmann A; Steffens S; Erlmeier F
Urol Int; 2022; 106(11):1168-1176. PubMed ID: 35654002
[TBL] [Abstract] [Full Text] [Related]
6. B7-H4 Immune Checkpoint Protein Affects Viability and Targeted Therapy of Renal Cancer Cells.
Emaldi M; Nunes-Xavier CE
Cells; 2022 Apr; 11(9):. PubMed ID: 35563753
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic importance of SUVmax values evaluated by 18F-FDG-PET/CT before nivolumab treatment in patients with metastatic renal cell carcinoma.
Gulturk I; Yilmaz M; Tacar SY; Tural D
Q J Nucl Med Mol Imaging; 2023 Sep; 67(3):223-229. PubMed ID: 34881845
[TBL] [Abstract] [Full Text] [Related]
8. Assessment of PD-L1 expression in patients with neuroblastoma and renal tumors.
Şener S; Poyraz A; Okur A; Pınarlı FG; Karadeniz C
Turk J Pediatr; 2021; 63(5):758-766. PubMed ID: 34738358
[TBL] [Abstract] [Full Text] [Related]
9. Identification of immunization-related new prognostic biomarkers for papillary renal cell carcinoma by integrated bioinformatics analysis.
Wu P; Xiang T; Wang J; Lv R; Ma S; Yuan L; Wu G; Che X
BMC Med Genomics; 2021 Oct; 14(1):241. PubMed ID: 34620162
[TBL] [Abstract] [Full Text] [Related]
10. Regulation of Immunity in Clear Cell Renal Carcinoma: Role of PD-1, PD-L1, and PD-L2.
Spirina L; Yurmazov Z; Usynin E; Kondakova I; Ladutko E; Choynzonov E
Curr Issues Mol Biol; 2021 Sep; 43(2):1072-1080. PubMed ID: 34563045
[TBL] [Abstract] [Full Text] [Related]
11. Programmed cell death-1 blockade in kidney carcinoma may induce eosinophilic granulomatosis with polyangiitis: a case report.
Harada M; Naoi H; Yasuda K; Ito Y; Kagoo N; Kubota T; Ichijo K; Mochizuki E; Uehara M; Matsuura S; Tsukui M; Koshimizu N
BMC Pulm Med; 2021 Jan; 21(1):6. PubMed ID: 33407304
[TBL] [Abstract] [Full Text] [Related]
12. [A CASE OF UNRESECTABLE METASTATIC RENAL CARCINOMA SUCCESSFULLY TREATED BY COMBINED MODALITY THERAPY WITH NIVOLUMAB AND SURGERY].
Ohmori N; Oki T; Tahara H
Nihon Hinyokika Gakkai Zasshi; 2021; 112(2):105-108. PubMed ID: 35444078
[TBL] [Abstract] [Full Text] [Related]
13. Diagnostic accuracy and safety of percutaneous MRI-guided biopsy of solid renal masses: single-center results after 4.5 years.
Cazzato RL; De Marini P; Auloge P; Leclerc L; Tricard T; Linder V; Jost M; Ramamurthy N; Lang H; Garnon J; Gangi A
Eur Radiol; 2021 Feb; 31(2):580-590. PubMed ID: 32851448
[TBL] [Abstract] [Full Text] [Related]
14. [Molecular mechanism analysis of Erzhi Wan in treatment of aging based on network pharmacology].
Shan S; Wang Q; Wang WL; Wu XY; Yan XJ; Liu HN
Zhongguo Zhong Yao Za Zhi; 2020 Jun; 45(12):2932-2937. PubMed ID: 32627469
[TBL] [Abstract] [Full Text] [Related]
15. The Clinical Value and Appropriateness Criteria of Upper Abdominal Magnetic Resonance Examinations in Patients Before and After Bariatric Surgery: a Study of 837 Images.
Lv H; Li M; Liu Y; Zhao L; Sun J; Cao D; Zeng N; Liu J; Liu Y; Bian S; Zhang P; Yang Z; Zhang Z; Wang Z
Obes Surg; 2020 Oct; 30(10):3784-3791. PubMed ID: 32483745
[TBL] [Abstract] [Full Text] [Related]
16. Galectin-9 expression as a poor prognostic factor in patients with renal cell carcinoma.
Jikuya R; Kishida T; Sakaguchi M; Yokose T; Yasui M; Hashizume A; Tatenuma T; Mizuno N; Muraoka K; Umemoto S; Kawai M; Yoshihara M; Nakamura Y; Miyagi Y; Sasada T
Cancer Immunol Immunother; 2020 Oct; 69(10):2041-2051. PubMed ID: 32424467
[TBL] [Abstract] [Full Text] [Related]
17. Increase in Efficacy of Checkpoint Inhibition by Cytokine-Induced-Killer Cells as a Combination Immunotherapy for Renal Cancer.
Dehno MN; Li Y; Weiher H; Schmidt-Wolf IGH
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349280
[TBL] [Abstract] [Full Text] [Related]
18. Outcomes and Safety of Biweekly and Monthly Nivolumab in Patients with Metastatic Renal Cell Carcinoma and Dialysis: Three Case Reports and Literature Review.
Osmán-García I; Congregado-Ruiz CB; Lendínez-Cano G; Baena-Villamarin C; Conde-Sanchez JM; Medina-López RA
Urol Int; 2020; 104(3-4):323-326. PubMed ID: 31914452
[TBL] [Abstract] [Full Text] [Related]
19. Soluble immune checkpoint-related proteins as predictors of tumor recurrence, survival, and T cell phenotypes in clear cell renal cell carcinoma patients.
Wang Q; Zhang J; Tu H; Liang D; Chang DW; Ye Y; Wu X
J Immunother Cancer; 2019 Nov; 7(1):334. PubMed ID: 31783776
[TBL] [Abstract] [Full Text] [Related]
20. NGS-analysis to the rescue: dual checkpoint inhibition in metastatic osteosarcoma - a case report and review of the literature.
Nuytemans L; Sys G; Creytens D; Lapeire L
Acta Clin Belg; 2021 Apr; 76(2):162-167. PubMed ID: 31635553
[No Abstract] [Full Text] [Related]
[Next]